DC Chemicals Limited
China
Product Name: 1400W dihydrochloride
Price: $300.0/100mg $550.0/250mg $1000.0/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

214358-33-5

214358-33-5 structure

214358-33-5 structure

Name: 1400W dihydrochloride
Chemical Name: 1400W (hydrochloride)
CAS Number: 214358-33-5
Molecular Formula: C₁₀H₁₇Cl₂N₃
Molecular Weight: 250.168
Catalog: Signaling Pathways Immunology/Inflammation NO Synthase
Create Date: 2018-12-29 16:38:24
Modify Date: 2024-01-20 18:45:37
1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.

Name	1400W (hydrochloride)
Synonyms	(1E)-N'-[3-(Aminomethyl)benzyl]ethanimidamide dihydrochloride 1400 W dihydrochloride MFCD03428622 Ethanimidamide, N'-[[3-(aminomethyl)phenyl]methyl]-, (1E)-, hydrochloride (1:2) 1400W dihydrochloride 1400W (Dihydrochloride)

Description	1400W dihydrochloride is a potent and selective inhibitor of human inducible NO synthase with Ki values of 7 nM.
Related Catalog	Signaling Pathways >> Immunology/Inflammation >> NO Synthase Research Areas >> Cardiovascular Disease Research Areas >> Inflammation/Immunology
Target	Ki: 7 nM (iNOS), 2 µM (nNOS), 50 µM (eNOS)[1]
In Vitro	1400W is a slow, tight binding inhibitor of human inducible nitric- oxide synthase (iNOS). The slow onset of inhibition by 1400W shows saturation kinetics with a maximal rate constant of 0.028 s-1 and a binding constant of 2.0 μM. Inhibition is dependent on the cofactor NADPH. 1400W is at least 5000-fold selective for iNOS versus eNOS. In contrast, inhibition of human neuronal NOS and endothelial NOS (eNOS) is relatively weaker, rapidly reversible, and competitive with L-arginine, with Ki values of 2 μM and 50 μM, respectively[1]. 1400W treatment inhibits iNOS expression without affecting nNOS or eNOS. 1400W also reduces NO, 3-NT and MDA production, and prevents neuronal cell apoptosis in cerebral cortex[2].
In Vivo	1400W potently (ED50=0.3 mg/kg) reduces the delayed vascular injury in rats attributable to LPS-induced iNOS but fails to exacerbate acute vascular leakage when given concurrently with LPS[1]. Administration of 1400W lowers NOx levels in all the experimental groups. In addition, lipid peroxidation, the percentage of apoptotic cells, and nitrated protein expression fall in the late post-hypoxia period (48 h and 5 days)[3].
Animal Admin	Rats: The effects of 1400W on plasma leakage are assessed in rats by determining the leakage of [125I]human serum albumin from plasma into organs. 1400W (0.1-10 mg/kg, subcutaneous) is dissolved in isotonic saline and administered either concurrently with endotoxin or 3 h following LPS administration (E. coli LPS, 3 mg/kg intravenously). Plasma leakage is then assessed 1 or 5 h after delivery of 1400W[1].
References	[1]. Garvey EP, et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997 Feb 21;272(8):4959-63. [2]. Shi Q, et al. 1400W ameliorates acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing the induction of inducible nitric oxide synthase in rat cerebral cortex microglia. Behav Brain Res. 2017 Feb 15;319:188-199. [3]. Rus A, et al. Inducible NOS inhibitor 1400W reduces hypoxia/re-oxygenation injury in rat lung. Redox Rep. 2010;15(4):169-78.

Boiling Point	329ºC at 760 mmHg
Molecular Formula	C₁₀H₁₇Cl₂N₃
Molecular Weight	250.168
Flash Point	152.7ºC
Exact Mass	249.079956
PSA	61.90000
LogP	4.02700
Vapour Pressure	0.000183mmHg at 25°C
Storage condition	-20℃

Personal Protective Equipment	Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR	NONH for all modes of transport